AR127448A1 - Derivados de benzo[h]quinazolin-4-amina para el tratamiento del cáncer - Google Patents
Derivados de benzo[h]quinazolin-4-amina para el tratamiento del cáncerInfo
- Publication number
- AR127448A1 AR127448A1 ARP220102893A ARP220102893A AR127448A1 AR 127448 A1 AR127448 A1 AR 127448A1 AR P220102893 A ARP220102893 A AR P220102893A AR P220102893 A ARP220102893 A AR P220102893A AR 127448 A1 AR127448 A1 AR 127448A1
- Authority
- AR
- Argentina
- Prior art keywords
- cancer
- treatment
- quinazolin
- benzo
- amine derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- WDBNXGHKWZMQOQ-UHFFFAOYSA-N benzo[h]quinazolin-4-amine Chemical class C1=CC2=CC=CC=C2C2=C1C(N)=NC=N2 WDBNXGHKWZMQOQ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención proporciona compuestos de fórmula (1) y sales farmacéuticamente aceptables de los mismos; en donde Rᵃ y Rᵇ son ambos -CH₃ o Rᵃ y Rᵇ juntos forman un -CH₂-CH₂-CH₂- o un resto de puenteo -CH₂-CH₂-CH₂-CH₂-; A es -CH₂- o -C(=O)-; T es -N(R¹¹)-, -N(R¹¹)-C(=O)-, -N(R¹¹)-S(O₂)-, -O-, -C(R¹²)(R¹³)-, -C=C(R¹²)₂, -S-, -S(O)-, -S(O₂)-, -S(O₂)-N(R¹⁴)- o -C(=O)-N(R¹⁴)-; y en donde R¹, R², R¹¹, R¹², R¹³ y R¹⁴ son como se definen en las reivindicaciones, así como métodos de uso de los compuestos para el tratamiento de enfermedades neoplásicas, tales como cáncer. Reivindicación 24: Una composición farmacéutica que comprende un compuesto de fórmula (1) como se ha definido en una cualquiera de las reivindicaciones 1 a 20 o una sal farmacéuticamente aceptable del mismo y opcionalmente un excipiente farmacéuticamente aceptable.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21204520 | 2021-10-25 | ||
EP22167146 | 2022-04-07 | ||
EP22186200 | 2022-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR127448A1 true AR127448A1 (es) | 2024-01-24 |
Family
ID=84361577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220102893A AR127448A1 (es) | 2021-10-25 | 2022-10-25 | Derivados de benzo[h]quinazolin-4-amina para el tratamiento del cáncer |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR127448A1 (es) |
TW (1) | TW202334097A (es) |
WO (1) | WO2023072913A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
KR101714799B1 (ko) * | 2008-12-30 | 2017-03-09 | 아르퀼 인코포레이티드 | 치환된 5,6-디히드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물 |
-
2022
- 2022-10-25 WO PCT/EP2022/079738 patent/WO2023072913A1/en active Application Filing
- 2022-10-25 AR ARP220102893A patent/AR127448A1/es unknown
- 2022-10-25 TW TW111140527A patent/TW202334097A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TW202334097A (zh) | 2023-09-01 |
WO2023072913A1 (en) | 2023-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019001077A1 (es) | Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer. | |
UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
ECSP22071009A (es) | Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead | |
AR055669A1 (es) | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. | |
CU20150084A7 (es) | Derivados del ácido 4-((1,1) bisfenil -4-il)-3-(3-fosfonopropanamido)butanoico,activo como inhibidores de nep(endopeptidasa neutral) | |
AR100073A1 (es) | Sulfonas heterocíclicas sustituidas con heteroarilos | |
AR097325A1 (es) | Pirroles anillados | |
AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
CL2023000387A1 (es) | Derivados de dioxoloisoquinolinona novedosos y uso de los mismos | |
MX9305947A (es) | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
UY27658A1 (es) | Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades | |
MX2020003993A (es) | Derivados de bencimidazol y sus usos. | |
AR118729A1 (es) | Inhibidor selectivo de la jak1 quinasa | |
PE20220704A1 (es) | Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmaceuticas que los contienen y sus usos como agentes proapoptoticos | |
AR057525A1 (es) | Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion | |
UY39181A (es) | COMPUESTOS Y COMPOSICIONES PARA INHIBIR LA ACTIVIDAD DE HIF2a Y SUS MÉTODOS DE USO | |
AR109168A1 (es) | Sales de derivados de 2,6-dimetilpirimidona y sus usos | |
AR124449A1 (es) | Inhibidores de sos1 y usos de los mismos | |
ECSP23017158A (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos | |
AR127448A1 (es) | Derivados de benzo[h]quinazolin-4-amina para el tratamiento del cáncer | |
AR117510A1 (es) | COMBINACIONES DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMAS | |
UY37745A (es) | Compuestos bicíclicos 5,6 fusionados y composiciones para el tratamiento de las enfermedades parasitarias | |
ECSP20026023A (es) | Derivados de piridinona y su uso como inhibidores selectivos de alk2. | |
AR088002A1 (es) | Derivados de metansulfonamida sustituidos con arilo o n-heteroarilo como ligandos del receptor vanilloide | |
AR128066A1 (es) | Compuesto heterocíclico de pirimidina y método de preparación y uso médico de los mismos |